Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Snowflake Inc (SNOW) vs Tempus AI (TEM) Price & Performance

Snowflake IncTrade

Price performance (Past 24H)

Key statistics

Snowflake Inc vs Tempus AI — how do they compare? Snowflake Inc trades at $331.89 (market cap $118.36B), while Tempus AI trades at $61.16 (market cap $11.67B). The key difference: Snowflake Inc is far larger — about 10.1× Tempus AI's market cap, and Snowflake Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

SNOWTEM
Market Cap
$118.36B$11.67B
Sector
TechnologyBroad Market / Factor
52-Week High
$356.47$103.25
52-Week Low
$121.11$41.55
Enterprise Value
$118.78B$12.30B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Snowflake Inc

Snowflake (SNOW) trades at $335.50, down 0.5% on the day, but maintains strong technical momentum with bullish moving averages and support at $331. The company demonstrates accelerating revenue growth, with Q2 2026 EPS beating expectations at $0.62 versus $0.45, and product revenue up 37% year-over-year. Recent news highlights AI-driven customer expansion and improved guidance, with the stock gaining 67% year-to-date in 2026.

Snowflake presents a growth-oriented investment case with robust AI adoption and enterprise expansion driving revenue acceleration. However, negative profitability metrics and elevated valuation multiples (P/S 21.25, P/B 55.06) pose significant risks. Analyst consensus remains strongly bullish with a $430 price target, but investors must weigh growth potential against persistent losses and competitive pressures in cloud analytics.

Tempus AI

Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).

Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Snowflake Inc

Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.

Read more on SNOW

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM